Third-Line and Later Susceptibility-Guided Helicobacter pylori Eradication Therapies: A Multicenter Study of Vonoprazan-Amoxicillin-Sitafloxacin/Rifabutin Regimens. [PDF]
Mori H +6 more
europepmc +1 more source
Bioluminescent <i>Mycobacterium abscessus</i> in <i>Galleria mellonella</i>: a preclinical screening tool for antimycobacterial compounds. [PDF]
Van Win T +5 more
europepmc +1 more source
Towards enhanced translational value: preclinical drug activity testing against actively multiplying, nutrient-starved and pellicle biofilm-embedded Mycobacterium abscessus. [PDF]
Meliefste HM +7 more
europepmc +1 more source
Therapeutic drug monitoring-guided treatment of XDR TB with an RpoB I491F mutation-a case report. [PDF]
Klingmüller A +12 more
europepmc +1 more source
Clinical Outcome of Rifabutin-based Treatment for Pulmonary Tuberculosis in Solid Organ Transplant Recipients. [PDF]
Yang J +14 more
europepmc +1 more source
Idiosyncratic Drug-Induced Neutropenia Following Pantoprazole, Moxifloxacin Hydrochloride, and Rifabutin Treatment for Helicobacter pylori: A Case Report. [PDF]
Furar E +2 more
europepmc +1 more source
Clinical Characteristics and Drug Resistance Profile of <i>Mycobacterium colombiense</i> Infection: A Study of 22 Cases. [PDF]
Mei L, Liang F, Liu S, Chen H.
europepmc +1 more source
Emergence of amoxicillin resistance in refractory <i>Helicobacter pylori</i> infection. [PDF]
Lin CY +11 more
europepmc +1 more source

